Velkommen til Lundbeck og Radiometer
Medicoindustrien byder velkommen til to nye medlemsvirksomheder
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with brain diseases. For this purpose, Lundbeck is engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world.
The company’s products are targeted at the disease areas within psychiatry and neurology. Lundbeck markets a number of different pharmaceuticals for the treatment of brain diseases. The most recently launched compounds include: Rexulti® (depression and schizophrenia), Brintellix® (depression) and Abilify Maintena® (schizophrenia).
Radiometer manufactures and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing and related IT management systems.
Founded in 1935 and headquartered in Copenhagen, Radiometer was a pioneer in blood gas testing, introducing the world’s first commercially available blood gas analyzer in 1954.
Today, Radiometer’s products and solutions are used in hospitals, clinics and laboratories in over 130 countries, to provide information on the most critical parameters in acute care testing.
Radiometer is part of Danaher Corporation’s (NYSE:DHR) life sciences and diagnostics platform.